Abstracts

ABSTRACT SUBMISSION for INTEREST 2022 is CLOSED

Abstract Deadline: Friday, 28 January 2022

Date limite de soumission des résumés : vendredi 28 janvier 2022



General Guidelines

Abstracts should contain the following four components:

  • Background: a concise statement of the issue under investigation or a hypothesis;
  • Materials & Methods: the experimental methods used (including the statistical analyses employed);
  • Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable, including statistical analyses;
  • Conclusions: a summary of findings that are supported by your results; concluding statements such as “the results will be discussed” are not acceptable.

Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements, or literature references are included. The maximum word count for the abstract body is 350 words.

Abstracts are considered as official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled. Abstract submitters for abstracts that are accepted for oral or mini-oral presentation will be eligible for travel and accommodation support.

We would like to advise abstract submitters to not pay registration until the decision regarding their abstract is known.

Abstract Submission

Abstract Submission is closed.

Authors could submit their abstracts electronically using the button “Submit Abstract”. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Abstracts can be submitted in either English or French.
Les résumés peuvent être soumis en anglais ou en français.

The registration fee will be waived for all candidates with an ACCEPTED abstract. IMPORTANT: free registration is offered to the presenting author of the abstract only.

You can read the full terms and conditions here: Terms & Conditions

Co-submission with the 24th International AIDS Conference (AIDS 2022) is allowed! If you have submitted your abstract to AIDS 2022, please indicate this on your abstract submission form.

Abstract Deadline: Friday, 28 January 2022

Date limite de soumission des résumés : vendredi 28 janvier 2022

Categories for Abstract Submission

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The International Conference Committee reserves the right to reassign your abstract to a more appropriate category.

Abstract topics

  • Antiretroviral treatment and HIV care / Traitement antirétroviral et prise en charge du VIH
  • Basic science and HIV cure / Sciences fondamentales et traitement du VIH
  • Community/civil society engagement / Engagement de la communauté et de la société civile
  • COVID-19 in Africa / COVID-19 en Afrique
  • Economics, innovative financing, development goals / Economie, financements innovants, objectifs de développement
  • Epidemiology / Épidémiologie
  • Health system strengthening / Renforcement des systèmes de santé
  • HIV co-infections, including hepatitis, tuberculosis, sexually transmitted infections, and (re)emerging pathogens / Co-infections du VIH, y compris l’hépatite, la tuberculose, les infections sexuellement transmissibles et les pathogènes (ré)émergents
  • HIV Prevention and new technologies (PrEP, vaccines, antibodies) / Prévention du VIH et nouvelles technologies (PrEP, vaccins, anticorps)
  • Implementation science, cost-effectiveness, and modelling / Science de la mise en œuvre, coût-efficacité et modélisation
  • Information technology innovations for HIV (mHealth, electronic records, social media, etc.) / Innovations des technologies de l’information pour le VIH (mHealth, dossiers électroniques, médias sociaux, etc.)
  • Key Populations: prevention and treatment challenges / Populations clés : défis en matière de prévention et de traitement
  • Knowledge translation to policy and programming / Transmission des connaissances aux politiques et aux programmes
  • Laboratory monitoring/diagnostics / Surveillance/diagnostic en laboratoire
  • Paediatrics and prevention of mother-to-child transmission (PMTCT) / Pédiatrie et prévention de la transmission mère-enfant (PTME)
  • Regulatory, ethical, and research conduct issues / Questions de réglementation, d’éthique et de conduite de la recherche
  • Socio-behavioural research / Recherche socio-comportementale
  • Structural determinants and interventions including stigma discrimination / Déterminants structurels et interventions, y compris la stigmatisation et la discrimination
  • Women and HIV / Femmes et VIH

Young Investigators/Postdoc/MD

The registration fee will be waived for all candidates with an ACCEPTED abstract. IMPORTANT: free registration is offered to the presenting author of the abstract only.

We are pleased to offer a 50% discount on the registration fee for young investigators without an accepted abstract.

The applicant should either:

  • be 35 years of age or younger; or
  • be a Master/PhD student; or
  • have obtained a MD / PhD degree in the last ten years

An application form needs to be completed by a supervisor and received by the conference secretariat at least 2 weeks prior to the start of the conference.

The conference secretariat will contact the young investigator with instructions regarding registration for the conference once the application has been received.

The Joep Lange Award

The highest-scoring abstract submitted to INTEREST will be designated with the Joep Lange Award. In honor of the co-founder of INTEREST, Prof. Joep Lange, this special recognition for outstanding research is announced during the conference each year. The recipient receives free registration plus travel and accommodation to attend the next INTEREST.

The Charles Boucher Award

Professors Charles Boucher and Joep Lange co-founded the INTEREST conference in 2007 to bring together a multidisciplinary team of experts to share knowledge and establish partnerships with the ultimate aim of improving the life quality of people living with HIV across the African continent.

Charles’ love for teaching, particularly regarding educating young researchers, was well known. He was an outstanding mentor, always ready to give advice and encouragement, and his passion for science and love of education will remain with us forever.

It has been almost a year since Charles passed away, and this award at a conference so close to his heart, honours his memory and contributes to the phenomenal legacy of our friend and colleague.

The Charles Boucher Award recipient receives free registration and all travel and accommodation costs to attend the next INTEREST conference are included.

Notification of Abstract Acceptance and Presentation Format

It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Please notify the Conference Secretariat if you have not received notification by the second week of March 2022. If your abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication

Accepted abstracts will be published in the Abstract Book. All abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts.